chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It been off and on that I have been profoundly fatigued and then I have times when I have irregular heartbeat. Upon exertion, i feel faint and have my heart racing along with nausea. I saw a cardiologist yesterday and I am currently wearing a heart monitor. Next week I am scheduled for a stress test on June 24th. I will be wearing the monitor for 2 weeks. I had a routine bloodwork which was normal.
While in observation period, pt reported feeling lightheaded and flushing, 12 minutes post-vaccination. Assessed by on-site EMS. Patient reported palpitations and chest-tightness. Vital signs taken by EMS. At 1815 BP 141/88 HR 104. At 1817, BP 160/101 HR 150. HR 168 per EMS. Based on tachycardia and symptoms, decision was made to transport to ER. Patient denied any significant health history or previous vaccine adverse events. Patient transported via ambulance.
achiness; sore arm; felt so bad; fever; felt tired that lasted all day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever) and FATIGUE (felt tired that lasted all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (achiness), PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever) and FATIGUE (felt tired that lasted all day). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (achiness), PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever) and FATIGUE (felt tired that lasted all day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: TCR form received. Event outcome updated where patient stated that she is fine.
pt recv vax 14MAY97 & 17JUN97 pt devel a lesion for about 1wk & then devel a gen varicella rash w/lesions on trunk, hands & face, etc;pt had greater than 100 lesions on trunk, hands & face;27JUN97 polymerase chain rxn revealed vax strain
testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 1st of 14 reports.   An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (drug being administered under FDA EUA). The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021065206 same reporter/drug/event, different patient.;US-PFIZER INC-2021065202 same reporter/drug/event, different patient.;US-PFIZER INC-2021065199 same reporter/drug/event, different patient.;US-PFIZER INC-2021065208 same reporter/drug/event, different patient.;US-PFIZER INC-2021065203 same reporter/drug/event, different patient.;US-PFIZER INC-2021065200 same reporter/drug/event, different patient.;US-PFIZER INC-2021065205 same reporter/drug/event, different patient.;US-PFIZER INC-2021065210 same reporter/drug/event, different patient.;US-PFIZER INC-2021065201 same reporter/drug/event, different patient.;US-PFIZER INC-2021065209 same reporter/drug/event, different patient.;US-PFIZER INC-2021065207 same reporter/drug/event, different patient.;US-PFIZER INC-2021065198 same reporter/drug/event, different patient.;US-PFIZER INC-2021065204 same reporter/drug/event, different patient.
the patient came in for a fluzone HD flu shot, but ended up mistakenly given an Pfizer covid shot. She was anxious when I called her to tell her the mistake on 09/25 Saturday. She came back later with her daughter to discuss about the error, she was calmer than.  I called her on 09/27 and 09/30 to check up on her and she ended up doing well and was ok.
Following the vaccine administration, the patient became flushed.  She laid down on a stretcher and complained of her heart fluttering and discomfort in the left arm, which was also the site of the injection.  Patient was taken to the ED and evaluated.
Frequent, loose bowel movements onset 12 days after completing course of Vivotif Berna (oral typhoid vaccine).  Continued symptoms without fever or rash 19 days after onset.  Taking intermittent diphenoxylate with temporary benefit.  Probiotic supplement has not helped. Patient treated with 3 day course of ciprofloxacin; stool analysis to be performed if symptoms fail to improve.
Around February, after the vaccine, is when I start having shortness of breath. There is a possibility it could have been before then. But after the vaccine is when I noticed. Around June is when it got worse. I also got the booster shot September 8, 2021.
pt recv vax 10APR96 & 24APR96 pt exp inj site rash;
On 7/8/21 around  8 P.M., the mental fog I experienced from the first Moderna COVID-19 shot returned. The symptoms once again included an inability to think, focus, or remember stuff with a spaced out feeling in my head and a decreased ability to hear. I was completely unable to function normally. On 7/9/21 around 3:00 P.M., the symptoms listed above continued and I was still unable to function normally in my daily activities and work. At 7/10/21 at 2:57 P.M., the mental fog appeared to be receding, but I was still not back at normal function. On 7/11/21 at 5:25 P.M.,  the remainder of the mental fog manifested as being a little slow mentally as I attempted to return to normal activities and work. On 7/12/21, as of 2:37 P.M., the mental fog was completely gone. No treatment was given for this side effect or the same one one I experienced with the first Moderna shot on 6/10/21 because I did not think that anything could be done.
seen 2MAY96 classic varicella rash less pruritic than usual,afeb;1MAY96 rash;
Pt received Prevnar vaccine on 11/25/15 and c/o chills, fever to 102, severe fatigue and extreme redness in left arm where vaccine given.  Pt's daughter called MD office on 11/26/15 about symptoms.  Pt went to MD office on 11/30/15 for follow-up.  MD stated pt will recover completely.
Patient received her 3 vaccines listed below. She was placed in waiting area for close monitoring. About 10 minutes later she started complaining of headache, dizziness, weakness and blurry vision. She was placed in a room on a supine position. She quickly started to breath faster, her O2 Sats dropped to low 90s, her skin was clammy and lose conscious for a few seconds (was not responding to questions). Given EPI Pen and jumped right up as in pain. O2 Sats improved and she was feeling better. About 5-7 minutes later, her O2 Sats started to drop again and she was breathing fast and feeling clammy again. A second dose of EPI Pen was given by doctor. She reported feeling better 2 minutes later. She was sent to ER for observation.
Itchiness on stomach for a week and then lower legs (calves and ankles; worse on right side). Legs are on Day 5 and still occuring; hoping it will go away like the stomach did after a week or so. I can see a few red bumps on the skin, but it's not really like a rash; seems to be more under the skin.  I don't know if it's just coincidence or not, but I can't think of anything else that's changed in my environment or eating to be causing this. I just wanted to get this on file in case you'd start seeing a trend. I've only been able to find the COVID arm rash/itching at the injection site, but I only had a very slight itch there a couple of days after the injection; nothing like what I'm having now.
@1143 Right after vaccination, pt became pale, dizzy and diaphoretic. Elevated feet up while waiting for the gurney. Nurses at bedside to keep pt safe. Pt felt slightly better and pt able to transfer from chair to gurney by himself with supervision. Moved to observation room. Placed on supine. Pt started to feel better. Color is better.  VS130/87 78HR 16 97%RA @1155 Started to reposition HOB to semi folwers slowly. Pt tolerating well. No sob noted. No s/sx of distress noted. Resp even and unlabored. Encouraged pt to drink more fluids and eat some crackers. Tol well.    @ 1210 Placed on high fowler's/ sitting position. Tol well. No sob noted. NO s/sx of distress noted. Pt stated that his doctor has constantly changing his BP meds recently. Pt did have a history of syncope related to hypoglycemia few years ago.  VS 152/85 (98) 69HR 18 100%   @1215 Sat pt on the side of the bed, dangling feet. Pt feels better, back to baseline. Pt slowly stood up and ambulated around the room. Asymptomatic. No sob noted. No s/sx of distress noted. Resp even and unlabored.
This is a 66-year-old male with past medical history of diabetes and hypertension who presents to the emergency room shortness of breath, fever, chills, cough and  low oxygen at home for the last 5 days.  He states he has vaccinated x3 against COVID.  He says symptoms have become more severe over the last few days and therefore came to the emergency room.  In the emergency room his O2 sat was 86%.  On room air.  An ABG shows a pH of 7.48, pCO2 29, PaO2 52 and O2 sat of 86%.  He has since been placed on high-flow oxygen.  His x-ray is positive for COVID pneumonia.  His lactic acid was 4.7 but his white count is normal.  He was given sepsis fluids in the emergency room.   See continuation... 66-year-old gentleman, was fully vaccinated with Moderna  for COVID-19 pneumonia, with booster dose, history of diabetes, that was admitted to the hospital on 1/21/2022, complaining of shortness of breath, tested positive for COVID-19 pneumonia. He was maintained on Bipap in PCU until 1/30/22 at which point he was transferred to the ICU. Patient was intubated, central line and arterial line were placed on 01/30/2022. [3] He initially did well with successful weaning of FiO2 but during multiple amounts of sedation vacation pt would become agitated and acutely hypoxic. Troponins were found to be elevated and he was placed on a heparin gtt and reached therapeutic levels. Hospital course complicated by Klebsiella pneumonia, ileus and AKI. Kidney function was slowly improving and pt was extremely responsive to diuresis. However, on 2/6 he became acutely hypoxic and tachycardic. Increasing FiO2, PEEP and suctioning requirements for secretion burden in addition to vent dyssynchrony. Sent for stat CT PE which was positive for bilat lower lobe PE despite being therapeutic on Heparin gtt. Pt had multiple episodes requiring ambu bag ventilation to increase O2 sats to above 70%. Increasing requirements of vasoactive infusions. Code status changed to partial code (no chest compressions or defibrillation) on 2/7. [2] Nimbex was discontinued and sedation was weaned after 4/4 train of four achieved. Maxed on vasoactive infusions, pt sustained MAPs <50 and O2 sats < 80% with 100% FiO2. AKI worsened after contrast dye load for PE scan. Pt became bradycardic after 1100cc UOP catheterized from bladder and 800cc of fecal matter suctioned from OG. Family decided to transition to comfort care on 2/8/22 and TOD 0933.  Moderna 3/19/21, 4/16/21, 12/16/21
This case was reported by a consumer via call center representative and described the occurrence of streptococcal infection in a 18-year-old female patient who received BEXSERO. On an unknown date, the patient received BEXSERO. On an unknown date, less than a year after receiving BEXSERO, the patient experienced streptococcal infection and thrush. On an unknown date, the outcome of the streptococcal infection and thrush were unknown. It was unknown if the reporter considered the streptococcal infection and thrush to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The anonymous consumer reported that her daughter was diagnosed with thrush after receiving her 1st dose of BEXSERO. The daughter had not received the 2nd dose of BEXSERO till the time of reporting. The consumer was not willing to provide the patient name or other details. This was a chat that was transferred from MI to the GRC. The reporter stated that her daughter was due to have her 2nd dose of BEXSERO on Monday, but she had been diagnosed with strep and thrush. The reporter wanted to know if it was okay for her daughter to had the vaccine while being on those drugs.
covid-19; covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 16Feb2021 at 12:00 as dose number unknown, single (Lot number: Wl9264), in left arm, on 09Mar2021 at 12:00 as dose number unknown, single (Lot number: En6203), in left arm and on 16Sep2021 at 11:00 as dose number unknown, single (Lot number: Fe3592) at the age of 65 years, in left arm for covid-19 immunisation; rosuvastatin (ROSUVASTATIN), from 01Jan2020 (Batch/Lot number: unknown) to 23May2022. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21May2022, outcome "not recovered" and all described as "covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23May2022) Positive, notes: tested positive 23May; (28May2022) Negative; (30May2022) Negative; (02Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient received other medication Rosuvastatin in two weeks of vaccination. The patient got Covid on 21May2022, tested positive 23May2022, started paxlovid 23May2022. Took 5-day course of paxlovid. Covid gone in 5 days. Tested negative on 28May2022 and 30May2022. Started getting symptoms and tested positive 02Jun2022. Sounds like paxlovid rebound. The patient had no other medical history and no known allergies.
One day after vaccine, paientt  reports he had pain and redness to vaccine sight as well as a rash to left arm and torso.  States rash lasted one week.  Rash resolved on it's own after one week.
Fatigue; ringing in both ears; Arm  was sore; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS, PAIN IN EXTREMITY, and FATIGUE in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020b21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced TINNITUS and PAIN IN EXTREMITY. On 01-Apr-2021, the patient experienced FATIGUE. On 01-Apr-2021, FATIGUE had resolved. On 02-Apr-2021, PAIN IN EXTREMITY had resolved. At the time of the report, TINNITUS had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 31-Mar-2021, at 7:30 am, the patient received first dose of vaccine in left non-dominate arm.  No concomitant medications were reported. Treatment information was not provided.
experienced nausea, headache, and then passed out with seizure like activity following GARDASIL 9 vaccination; experienced nausea, headache, and then passed out with seizure like activity following GARDASIL 9 vaccination; experienced nausea, headache, and then passed out with seizure like activity following GARDASIL 9 vaccination; experienced nausea, headache, and then passed out with seizure like activity following GARDASIL 9 vaccination; This spontaneous report was received from  the patient's mother referring to a 17 years old female patient with no known allergies.   The patient was born with one kidney. The patient's medical history was not provided.      On 12-AUG-2019, the patient was vaccinated with the "1st dose of the three-dose regimen" of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) on an unspecified arm (dose, frequency, route, lot# and expiration date were not provided) for HPV. Concomitant therapies included unspecified meningitis vaccine shot administered simultaneously.  On the same date, the patient experienced nausea, headache, and then passed out (loss of consciousness) with seizure like activity following HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) vaccination." On an unspecified date, routine lab work was performed but the results were not provided.  No treatment was prescribed for the event.  Later on the same date, the patient recovered from loss of consciousness, headache, nausea and seizure.    The causal relationship between the events and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was not provided.  Upon internal review, loss of consciousness and seizure were considered medically significant.
Woman presented to the Health Department on 10/25/21 for a Moderna booster. The RN administered a full-dose (.5ml) Moderna vaccine. The patient was notified of the error and denied any side effects at that time. She was advised to contact the health department with any questions or concerns.
fainted about 1-2 minutes after getting her injection. She was standing by her mother while her sister got her shot.
This spontaneous case was reported by a patient and describes the occurrence of HYPOACUSIS (A little hearing loss (Under 10 percent) a couple of weeks after the first booster), ECZEMA (Eczema on both legs and both Arms a couple of weeks after the first booster, Diagnosed with Eczema after the first booster) and TINNITUS (Ringing / Constant buzzing primarily in the right ear a couple of weeks after the first booster) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 024M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jan-2022, the patient experienced HYPOACUSIS (A little hearing loss (Under 10 percent) a couple of weeks after the first booster), ECZEMA (Eczema on both legs and both Arms a couple of weeks after the first booster, Diagnosed with Eczema after the first booster) and TINNITUS (Ringing / Constant buzzing primarily in the right ear a couple of weeks after the first booster). The patient was treated with TACROLIMUS for Eczema, at an unspecified dose and frequency and BETAMETHASONE for Eczema, at an unspecified dose and frequency. At the time of the report, HYPOACUSIS (A little hearing loss (Under 10 percent) a couple of weeks after the first booster), ECZEMA (Eczema on both legs and both Arms a couple of weeks after the first booster, Diagnosed with Eczema after the first booster) and TINNITUS (Ringing / Constant buzzing primarily in the right ear a couple of weeks after the first booster) had not resolved.            No concomitant medications were provided by the reporter. It was reported that on 15-Jan-2022, the patient was diagnosed with Eczema.  The doctor prescribed Tacrolimus Ointment (Did not work), then prescribed Betamethasone 5 percent  ointment (did not helped much), Desoximethasone 0.25 percent Ointment (not started using it yet). She states that all side effects are still going on and she does not want to receive a 2nd booster dose of Moderna COVID-19 vaccine.
On Sunday, 03/09/2003 in the evening the patient began experiencing a lot of pain to (l) shoulder with throbbing and shooting pain. Pt reported that that evening she also had difficulty sleeping, rapid heart rate, and three enlarged lymph nodes to the axillary area and a fever of a 102.  She measured her lymph nodes and reported that the largest was six inches and the other two were about three inches.  She saw her primary care physician, on Monday 3/10/2003 and was given ibuprofen 500mg, Tylenol and Benadryl.  She was also given a sling for her arm.  As of 3/14/2003 patient with 3 large nodes of 3", 3" and 2" totaling 8 inches in diameter and nodes began to develop color but no fluctuance.  Dr consulted with CDC clinician and pt started on Cephalexin 500 QID for 10 days on 03/14/2003.
Child received hepatitis A #1 6/29/06 in the morning. Child afebrile with a slight cold. Within 24 hours of receiving Hep A #1, child went to ER with fever of 104 F per mother. ER diagnosis: upper respiratory infection - treatment with amoxicillin and Tylenol. Returned to ER 2 days later. Fever 103 F. Diagnosis: gastritis.
Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff".; myocarditis; swollen ankles; Potential heart Palpitations; body falling apart; back issues; Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient in her 30's received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single and administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "history drug/alcohol abuse" (unspecified if ongoing), notes: history drug/alcohol abuse; "history drug/alcohol abuse" (unspecified if ongoing), notes: history drug/alcohol abuse; "HPV" (unspecified if ongoing), notes: previous report, unconfirmed but mentioned HPV. The patient's concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant) with onset 2021, outcome "unknown", described as "myocarditis"; JOINT SWELLING (non-serious) with onset 2021, outcome "unknown", described as "swollen ankles"; PALPITATIONS (non-serious) with onset 2021, outcome "unknown", described as "Potential heart Palpitations"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "body falling apart"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "back issues"; DANDRUFF (non-serious) with onset 2021, outcome "unknown", described as "Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff"; SKIN DISORDER (non-serious), outcome "unknown", described as "Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff".". The lot number for bnt162b2 was not provided and will be requested during follow up.